Strength
100 mg/10mL
Manufacturer
Janssen Biotech, Inc.NDC
57894003001
Classification
Brand
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
3/19/2025
Active Ingredients
INFLIXIMABApproval Type
Biologic (BLA)
FDA Application
BLA103772On Market Since
8/24/1998
Pharmacological Classes
Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
ENBREL 25 MG/0.5 ML SYRINGE
Brand
58406001004•Immunex Corporation
$2076.2308
per ML
ENBREL 50 MG/ML SYRINGE
Brand
58406002104•Immunex Corporation
$2080.7423
per ML
ENBREL 50 MG/ML MINI CARTRIDGE
Brand
58406004404•Immunex Corporation
$2081.5847
per ML
ENBREL 50 MG/ML SURECLICK
Brand
58406003204•Immunex Corporation
$2083.3498
per ML
CIMZIA 2X200 MG/ML(X3)START KT
Brand
50474071081•UCB, Inc.
$6072.5137
per EA
CIMZIA 2X200 MG/ML SYRINGE KIT
Brand
50474071079•UCB, Inc.
$6112.3912
per EA
SIMPONI 100 MG/ML PEN INJECTOR
Brand
57894007102•Janssen Biotech, Inc.
$7446.2126
per ML
SIMPONI 50 MG/0.5 ML PEN INJEC
Brand
57894007002•Janssen Biotech, Inc.
$12974.5178
per ML
SIMPONI 50 MG/0.5 ML SYRINGE
Brand
57894007001•Janssen Biotech, Inc.
$12977.2440
per ML